Philadelphia Pharmaceuticals Company (ASE:PHIL)

ASE:PHIL Revenue

Philadelphia Pharmaceuticals Company had revenue of 2.17M JOD in the quarter ending March 31, 2026, a decrease of -7.02%. This brings the company's revenue in the last twelve months to 9.00M, up 1.92% year-over-year. In the year 2025, Philadelphia Pharmaceuticals Company had annual revenue of 9.17M with 4.64% growth.

• Revenue (ttm): 9.00M
• Revenue Growth: +1.92%
• P/S Ratio: 1.43
• Revenue / Employee: 69.81K
• Employees: 129
• Market Cap: 12.90M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.17M	406.53K	4.64%
Dec 31, 2024	8.76M	357.51K	4.25%
Dec 31, 2023	8.40M	-10.46K	-0.12%
Dec 31, 2022	8.42M	1.81M	27.48%
Dec 31, 2021	6.60M	-1.05M	-13.77%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error